NCT06171607View on ClinicalTrials.gov

Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses

PHASE1RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 5, 2020

Primary Completion Date

November 5, 2026

Study Completion Date

November 5, 2027

Conditions
Breast Carcinoma
Interventions
PROCEDURE

Contrast-Enhanced Ultrasound

Undergo CEUS

DRUG

Perflutren Lipid Microspheres

Given IV

DRUG

Sulfur Hexafluoride Lipid Microspheres

Given IV

Trial Locations (2)

90033

RECRUITING

Los Angeles County-USC Medical Center, Los Angeles

RECRUITING

USC / Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Southern California

OTHER

NCT06171607 - Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses | Biotech Hunter | Biotech Hunter